Literature DB >> 10230511

Identification of IY81149 and its metabolites in the rat plasma using the on-line HPLC/ESI mass spectrometry.

S W Myung1, H K Min, C Jin, M Kim, S M Lee, G J Chung, S J Park, D Y Kim, H W Cho.   

Abstract

Reversed-phase high-performance liquid chromatography/mass spectrometry (HPLC/MS) with an electrospray ionization (ESI) interface was applied to the identification of metabolites of IY 81149 in the rat plasma. Fragments obtained using collision-induced dissociation (CID) in both positive and negative modes were utilized to elucidate the structure of metabolites. The eluent from the conventional HPLC column was split and directly introduced into an ESI-mass spectrometer for the identification of the structures. The CID technique allowed the sensitive identification of sulfonyl-IY81149 and hydroxy-IY81149 from the rat plasma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10230511     DOI: 10.1007/bf02976545

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  3 in total

1.  An improved LC-MS/MS method for quantitative determination of ilaprazole and its metabolites in human plasma and its application to a pharmacokinetic study.

Authors:  Gan Zhou; Zhi-rong Tan; Wei Zhang; Dong-sheng Ou-Yang; Yao Chen; Dong Guo; Ying-zi Liu; Lan Fan; Han-wu Deng
Journal:  Acta Pharmacol Sin       Date:  2009-08-24       Impact factor: 6.150

2.  Pharmacokinetic drug interaction and safety after coadministration of clarithromycin, amoxicillin, and ilaprazole: a randomised, open-label, one-way crossover, two parallel sequences study.

Authors:  Byung Hak Jin; Byung Won Yoo; Jungsin Park; Jung Hye Kim; Jun Yeon Lee; Jae Soo Shin; Min Soo Park
Journal:  Eur J Clin Pharmacol       Date:  2018-05-30       Impact factor: 2.953

3.  Identification of the New In Vivo Metabolites of Ilaprazole in Rat Plasma after Oral Administration by LC-MS: In Silico Prediction of the H+/K+-ATPase Inhibitor.

Authors:  Guiqiu Zhang; Kaijing Guo; Pengfei Wang; Yingbo Shan; Chen Ma
Journal:  Molecules       Date:  2021-01-16       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.